BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4363063)

  • 1. Effect of murine milk samples and human breast tissues on human leukocyte migration indices.
    Black MM; Moore DH; Shore B; Zachrau RE; Leis H
    Cancer Res; 1974 May; 34(5):1054-60. PubMed ID: 4363063
    [No Abstract]   [Full Text] [Related]  

  • 2. Cellular hypersensitivity of gp55 of RIII-murine mammary tumor virus and gp55-like protein of human breast cancers.
    Black MM; Zachrau RE; Dion AS; Shore B; Fine DL; Leis HP; Williams CJ
    Cancer Res; 1976 Nov; 36(11 Pt 1):4137-42. PubMed ID: 184925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indirect leukocyte migration inhibition in breast cancer and benign breast disease patients by mouse mammary tumor virus grown in feline kidney cells.
    McCoy JL; Tagliabue A; Ames RE; Teramoto YA; Cannon GB; Alford C; Herberman RB; Schlom J
    J Natl Cancer Inst; 1984 Mar; 72(3):569-76. PubMed ID: 6321840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigens of murine mammary tumor virus: applications to human breast cancer.
    Sibal LR; Rubin DJ
    J Natl Cancer Inst; 1972 Apr; 48(4):1177-80. PubMed ID: 4336881
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment of cellular immune response to cancer of the breast.
    Herberman RB
    Ann Clin Lab Sci; 1979; 9(6):467-73. PubMed ID: 229763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of the simultaneous cell-mediated immune reactivity to RIII murine mammary tumor virus glycoprotein 55 and human breast cancer tissues.
    Zachrau RE; Black MM; Dion AS; Shore B; Williams CJ; Leis HP
    Cancer Res; 1978 Oct; 38(10):3414-20. PubMed ID: 80264
    [No Abstract]   [Full Text] [Related]  

  • 7. Detection of cell-mediated immune reactivity of breast cancer patients by the leukocyte adherence inhibition response to MCF-7 extracts.
    Rudczynski AB; Dyer CA; Mortensen RF
    Cancer Res; 1978 Nov; 38(11 Pt 1):3590-4. PubMed ID: 81103
    [No Abstract]   [Full Text] [Related]  

  • 8. Cellular immunity to autologous breast cancer and RIII-murine mammary tumor virus preparations.
    Black MM; Zachrau RE; Shore B; Dion AS; Leis HP
    Cancer Res; 1978 Jul; 38(7):2068-76. PubMed ID: 207421
    [No Abstract]   [Full Text] [Related]  

  • 9. Radioimmunoassay for protein p28 of murine mammary tumor virus in organs and serum of mice and search for related antigens in human sera and breast cancer extracts.
    Hendrick JC; François C; Calberg-Bacq CM; Colin C; Franchimont P; Gosselin L; Kozma S; Osterrieth PM
    Cancer Res; 1978 Jun; 38(6):1826-31. PubMed ID: 206358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor immunity in breast cancer patients. Biologic and therapeutic implications.
    Black MM; Zachrau RE
    J Reprod Med; 1979 Jul; 23(1):21-32. PubMed ID: 226697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukocyte migration inhibition response to breast cancer antigens and to mouse mammary tumor virus in women with primary breast cancer.
    Fukuda M; Wanebo HJ; Tsuei L; Sarkar NH
    Surg Forum; 1978; 29():167-9. PubMed ID: 233830
    [No Abstract]   [Full Text] [Related]  

  • 12. Leukocyte migration inhibition responses to MCF-7, murine mammary tumor virus, and Thomsen-Friedenreich antigen in a series of cancer patients.
    Bernhard MI; Wanebo HJ; Helm J; Pace RC; Kaiser DL
    Cancer Res; 1983 Apr; 43(4):1932-7. PubMed ID: 6299532
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cross reaction between human breast cancer, mastopathy and murine mamma carcinoma: localization of the antigen in type-A-particle-virus].
    Müller M; Kemmer C; Zotter S; Grobbman H; Micheel B
    Arch Geschwulstforsch; 1973; 41(2):100-6. PubMed ID: 4354922
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of cell-mediated antiviral immunity and macrophage activation in C3H/HeN mice infected with mouse mammary tumor virus.
    Tagliabue A; Boraschi D; McCoy JL
    J Immunol; 1980 May; 124(5):2203-8. PubMed ID: 6245137
    [No Abstract]   [Full Text] [Related]  

  • 15. [Expression of antigens immunologically related to the antigens of the mouse mammary tumor virus in the tissue of human breast tumors].
    Remennik LV; Litvinov SV; Kriukova IN; Chuev IuV
    Biull Eksp Biol Med; 1985 Jun; 99(6):734-6. PubMed ID: 2990606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukocyte migration inhibition among breast cancer patients in response to various oncogenic viruses.
    Fukuda M; Wanebo HJ; Tsuei L; Ashikari R; Sarkar NH
    J Natl Cancer Inst; 1980 Mar; 64(3):431-7. PubMed ID: 6243720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunological cross reaction between human breast cancer and mammopathy and virus-producing breast carcinomas of the mouse].
    Müller M; Zotter S; Grossmann H; Kemmer C
    Arch Geschwulstforsch; 1972; 40(4):285-99. PubMed ID: 4346686
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunological studies on human breast carcinoma and mouse mammary tumors.
    Priori ES; Anderson DE; Williams WC; Dmochowski L
    J Natl Cancer Inst; 1972 Apr; 48(4):1131-5. PubMed ID: 4336878
    [No Abstract]   [Full Text] [Related]  

  • 19. Specificity of cell-mediated immunity in mouse-human cross-reactions: formal discussion.
    Parks W
    Cancer Res; 1976 Feb; 36(2 pt 2):775-6. PubMed ID: 175937
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognostically favorable immunogens of human breast cancer tissue: antigenic similarity to murine mammary tumor virus.
    Black MM; Zachrau RE; Shore B; Moore DH; Leis HP
    Cancer; 1975 Jan; 35(1):121-8. PubMed ID: 162850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.